scholarly journals Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions

BMJ ◽  
1986 ◽  
Vol 293 (6538) ◽  
pp. 51-51
Author(s):  
P. Cohen
Author(s):  
M. L. Maksimov ◽  
N. M. Kiseleva ◽  
D. G. Semenikhin ◽  
B. K. Romanov

Non-steroidal anti-inflammatory drugs (NSAIDs) are included in a pharmacological group of drugs with different chemical structures providing anti-inflammatory, analgesic and antipyretic actions, as well as antiplatelet action to a certain degree. Unfortunately, NSAIDs can cause a wide range of adverse reactions (AR) posing a serious risk to the health and life of patients. Therefore, the rational use of NSAIDs should include methods for effective prevention of drug complications. Many NSAIDs have a pronounced therapeutic effect, simultaneously causing many undesirable effects, so the drug shall be chosen considering the development of predicted side effects and modern algorithms. According to clinical recommendations, risk factors and administration of safer NSAIDs shall be considered as the main prevention method. Besides, it is possible to protect the patient from the upper gastrointestinal tract complications using proton pump inhibitors. It should be noted that there are no effective medication methods for kidney and liver protection to reduce the risk of NSAID-associated complications.


2021 ◽  
Vol 5 (2) ◽  
pp. 96-101
Author(s):  
V.B. Vasilyuk ◽  
◽  
G.I. Syraeva ◽  
M.V. Faraponova ◽  
◽  
...  

Gout is one of the most common forms of inflammatory arthritis. Medical care for gout includes non-steroidal anti-inflammatory drugs (NSAIDs). This paper reviews the efficacy and safety of NSAIDs prescribed for the acute attack of gout, in particular, AMBENIUM® parenteral. It was demonstrated that phenylbutazone is a powerful NSAID that provides significant analgesic and anti-inflammatory effects. Considering a broad spectrum of adverse reactions of NSAIDs, these agents should be prescribed and used under in-depth analysis of patient’s condition, comorbidities and the level of their decompensation, and potential drug interactions. In addition, optimal dosages and duration of NSAID treatment are of particular importance. The authors conclude that AMBENIUM® parenteral is an effective and safe therapeutic modality for gout. Its profile and risk/benefit ratio are regarded as “favorable” compared to other NSAIDs. KEYWORDS: gout, arthritis, pain, non-steroidal anti-inflammatory drugs, parenteral, efficacy, safety. FOR CITATION: Vasilyuk V.B., Syraeva G.I., Faraponova M.V. Efficacy and safety of non-steroidal anti-inflammatory drugs for acute attack of gout. Russian Medical Inquiry. 2021;5(2):96–101. DOI: 10.32364/2587-6821-2021-5-2-96-101.


2012 ◽  
Vol 5 (1) ◽  
pp. 65-67 ◽  
Author(s):  
Fahad Al-Ghimlas ◽  
Nasser Al-Ahmed ◽  
Sean Mace

Non-steroidal anti-inflammatory drugs are used daily by millions of patients worldwide for the management of various inflammatory diseases. Many well-documented adverse reactions are related to the use of these drugs. We report a fifty-four year-old woman with anaphylaxis after ingestion of ibuprofen liquid in a gelatin capsule. Eventually this was concluded to have resulted from hypersensitivity to the gelatin component of the capsule, which was likely IgE-mediated because of the positive skin test to gelatin. Gelatin allergy is only relevant for patients ingesting specific capsule formulation. The allergist/clinical immunologist must keep in mind the possibility of gelatin allergy.


1997 ◽  
Vol 78 (1) ◽  
pp. 74-78 ◽  
Author(s):  
Papa Giuseppe ◽  
Romano Antonino ◽  
Del Bono Alessandro ◽  
Quaratino Donato ◽  
Di Fonso Marina ◽  
...  

2021 ◽  
pp. 177-182
Author(s):  
Abeer Feteih ◽  
Lydia Zhang ◽  
Geneviève Genest ◽  
Ghislaine Annie Clarisse Isabwe

1987 ◽  
Vol 25 (21) ◽  
pp. 81-84

Non-steroidal anti-inflammatory drugs (NSAIDs) are highly effective in relieving the symptoms of arthritis, but several NSAIDs have been withdrawn in recent years because of serious adverse reactions. The balance between their benefits and risks is therefore being widely reappraised. Concern is greatest about the elderly, who receive most prescriptions of NSAIDs, and who are reputed to be at greater risk. We here attempt to assess the risk and to compare the safety of the NSAIDs now in use for 6 years or more.


Sign in / Sign up

Export Citation Format

Share Document